128 related articles for article (PubMed ID: 6341486)
1. Inhibition of isolation of Escherichia coli in blood cultures by trimethoprim-sulfamethoxazole.
Hackbarth CJ; Ernst JD; Sande MA
J Infect Dis; 1983 May; 147(5):964-5. PubMed ID: 6341486
[No Abstract] [Full Text] [Related]
2. Trimethoprim resistance and single-agent use.
Maskell R; Pead L
Lancet; 1989 Sep; 2(8662):557-8. PubMed ID: 2570249
[No Abstract] [Full Text] [Related]
3. In vitro activity of ciprofloxacin compared to trimethoprim-sulfamethoxazole against Campylobacter spp., Shigella spp. and Enterotoxigenic Escherichia coli causing travellers' diarrhea in Egypt.
Mikhail IA; Bourgeois AL; Hyams KC; Podgore JK; Lissner CR; Walz S
Scand J Infect Dis; 1987; 19(4):479-81. PubMed ID: 3313681
[TBL] [Abstract][Full Text] [Related]
4. [Antibiotic resistance of Escherichia coli. Importance of the resistance to trimethoprim-sulfamethoxazole].
Riou B; Richard C; Rimailho A; Coquin Y; Rottman E; Auzepy P
Ann Med Interne (Paris); 1985; 136(5):412-5. PubMed ID: 3904566
[TBL] [Abstract][Full Text] [Related]
5. Co-trimoxazole susceptibility tests improved with separate trimethoprim and sulfamethoxazole disks.
Amyes SG
J Clin Microbiol; 1981 Apr; 13(4):613-7. PubMed ID: 7014612
[TBL] [Abstract][Full Text] [Related]
6. Resistance of urinary tract isolates of Escherichia coli to trimethoprim, cotrimoxazole and ampicillin.
Bailey RR; Peddie BA
N Z Med J; 1988 Apr; 101(844):216-7. PubMed ID: 3283613
[No Abstract] [Full Text] [Related]
7. [Sensitivity to sulfamethoxazole-trimethoprim of Escherichia coli isolated from claves (author's transl)].
Wierup M
Nord Vet Med; 1974 Nov; 26(11):626-33. PubMed ID: 4615298
[No Abstract] [Full Text] [Related]
8. Five-year survey of changing patterns of susceptibility of bacterial uropathogens to trimethoprim-sulfamethoxazole and other antimicrobial agents.
Alon U; Davidai G; Berant M; Merzbach D
Antimicrob Agents Chemother; 1987 Jan; 31(1):126-8. PubMed ID: 3551824
[TBL] [Abstract][Full Text] [Related]
9. Incidence of trimethoprim-sulfamethoxazole-resistant enterobacteriaceae among transplant recipients.
Wells CL; Podzorski RP; Peterson PK; Ramsay NK; Simmons RL; Rhame FS
J Infect Dis; 1984 Nov; 150(5):699-706. PubMed ID: 6387000
[TBL] [Abstract][Full Text] [Related]
10. Prevention of emergence of bacterial resistance with the combination of sulphamethoxazole and trimethoprim.
Grüneberg RN; Emmerson AM
Eur J Clin Microbiol; 1982 Jun; 1(3):155-8. PubMed ID: 6756907
[TBL] [Abstract][Full Text] [Related]
11. Quality control of susceptibility tests with 5-micrograms trimethoprim disks.
Barry AL; Jones RN; Gavan TL
J Clin Microbiol; 1984 Oct; 20(4):817-9. PubMed ID: 6436317
[TBL] [Abstract][Full Text] [Related]
12. Trimethoprim/sulphamethoxazole resistance in Escherichia coli and Klebsiella spp. urinary isolates.
Obaseiki-Ebor EE
Afr J Med Med Sci; 1988 Sep; 17(3):175-9. PubMed ID: 2845759
[TBL] [Abstract][Full Text] [Related]
13. Development of plasmid-mediated resistance in Vibrio cholerae during treatment with trimethoprim-sulfamethoxazole.
Dupont MJ; Jouvenot M; Couetdic G; Michel-Briand Y
Antimicrob Agents Chemother; 1985 Feb; 27(2):280-1. PubMed ID: 3885851
[TBL] [Abstract][Full Text] [Related]
14. Bactericidal activity of trimethoprim alone and in combination with sulfamethoxazole on susceptible and resistant Escherichia coli K-12.
Amyes SG
Antimicrob Agents Chemother; 1982 Feb; 21(2):288-93. PubMed ID: 7041815
[TBL] [Abstract][Full Text] [Related]
15. [Present status of the resistance of enterobacteria to the combination of a sulfonamide and trimethoprim].
Riou B; Richard C; Rimailho A; Bottineau G; Coquin Y; Auzepy P
Presse Med; 1984 Jun; 13(26):1637-8. PubMed ID: 6234571
[No Abstract] [Full Text] [Related]
16. [Trimethoprim-sulphamethoxazole--a study on resistance patterns in Escherichia coli].
Madsen ST
Tidsskr Nor Laegeforen; 1973 Nov; 93(30):2244-5. PubMed ID: 4588011
[No Abstract] [Full Text] [Related]
17. Investigations on the mode of action of the combination sulfamethoxazole-trimethoprim.
Angehrn P; Then R
Chemotherapy; 1973; 19(1):1-10. PubMed ID: 4583774
[No Abstract] [Full Text] [Related]
18. Dissemination of clonal groups of uropathogenic Escherichia coli is not a significant contributor to trimethoprim and sulfamethoxazole resistance in Galway, Ireland.
Morris D; Ni Chulain M; Cormican M
Int J Antimicrob Agents; 2007 Jul; 30(1):97-8. PubMed ID: 17459666
[No Abstract] [Full Text] [Related]
19. [Potentiation by EDTA and levallorphan of the effect of sulfamethoxazole-trimethoprim on Escherichia coli].
Then R
Experientia; 1972 Sep; 28(9):1118-9. PubMed ID: 4198708
[No Abstract] [Full Text] [Related]
20. [In vitro sensitivity of human pathogens to the drug combination sulfamethoxazole-trimethoprim].
Lebek G; Wiedmer E
Schweiz Med Wochenschr; 1971 Sep; 101(38):1385-90. PubMed ID: 4946735
[No Abstract] [Full Text] [Related]
[Next] [New Search]
